A Phase i Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients with Solid Tumor Malignancies

Paula M. Fracasso, Sherry A. Goodner, Jonathan D. Wildi, Michael J. Naughton, Gerald P. Linette, Ramaswamy Govindan, Benjamin R. Tan, Kristie A. Blum, Gary J. Jones, Tillman E. Pearce, Daniel J. Levitt, Gerald H. Clamon

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase i Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients with Solid Tumor Malignancies'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science